Med Spa Business
By Faisal Darwiche, NP — 2026-06-05
Most "med spa profit margin" articles are written by software vendors and franchise sellers quoting numbers they've never run. I've built an aesthetic practice up to ten treatment rooms and sold it, and I run three practices today. So when I give you a number, it's a number I've actually watched leave or land in my account — at both the ten-room scale and the one-room scale.
Done right, yes — aesthetic services can carry strong margins. On core injectables, a syringe of filler can land near a 70% gross margin in well-run practices. But gross margin isn't profit until it clears rent, payroll, and fixed costs, and there's no profitability timeline anyone can honestly promise you. Typical results vary; these are illustrative ranges, not projections.
In my experience, a lean med spa typically opens for $80,000–$150,000, and a full buildout with multiple treatment rooms and devices can run $250,000 or more. Real estate is the biggest swing — leasing existing medical space costs a fraction of building from a raw shell. These are illustrative ranges from what I've seen, not quotes or guarantees. For the line-by-line cost question on its own, see how much it costs to open a med spa.
Here's how I break a startup budget. Ranges below are planning frames, not a price list. I cover every line in detail in how much it costs to open a med spa.
Core injectables can carry strong gross margins. On a syringe of filler, where the product commonly runs $300–$600 at wholesale and the treatment is priced well above that, I've seen gross margins land near 70% — something like $400–$600 net per syringe in well-run practices. But a gross margin is not profit. It's what's left before rent, payroll, and fixed costs. Typical results vary; these are illustrative ranges, not income projections.
Because the margin is per service and the costs are per month. A 70% gross margin on a syringe looks incredible until you put rent, payroll, insurance, software, and your medical-director fee on top of it. The math only works at volume. This is why I push new owners to model a slow first quarter, not a perfect one. If your plan only works at full capacity, it's a hope, not a plan.
Know your two big consumables cold before you price anything: filler at $300–$600 per syringe wholesale, and a 100-unit vial of neuromodulator. Those numbers drive every per-treatment margin you'll ever quote, so I track them obsessively.
One operator decision quietly decides whether your tox margin survives a real month: how you handle follow-ups. I price neuromodulator by the unit, so I don't advertise "complimentary touch-ups." Under per-unit pricing, every free unit is real product cost you're giving away.
Instead, I treat a patient's first couple of visits as deliberate dose individualization — we dial in their dose, and once it's dialed in, follow-ups are rare and additional units are charged at standard rates. The practices that promise "free touch-ups" almost always price *per area* and quietly inflate the per-area price to cover the extra product. The "free" touch-up was pre-paid all along. Small pricing decisions like that are the difference between a margin that looks good on paper and one that holds up.
Aesthetic services can carry strong margins, but profitability depends on your pricing, your patient volume, your fixed costs, and how you run the business day to day. There's no profitability timeline I can promise you. Startup cost is what it takes to open the doors; profit is a separate question with no fixed answer. Be skeptical of anyone who quotes you a "profitable in X months" number — they're selling something.
Three moves. One: lease existing medical space instead of building from a shell — the biggest single cost lever. Two: open with a narrow, high-margin menu and add devices once they pay for themselves. Three: keep real working capital so a slow first quarter doesn't end the business. Underbudgeting the cushion ends more practices than any device line item ever will. (If you're an NP, the NP-specific launch steps and the med spa business plan walk this in order.)
On core injectables like filler, I've seen gross margins near 70% — roughly $400–$600 net per syringe in well-run practices — but that's gross margin, not net profit. Net profit depends on your rent, payroll, and volume. Typical results vary; these are illustrative ranges.
In my experience, a lean med spa typically opens for $80,000–$150,000, and a full buildout can exceed $250,000. Real estate and device choices drive most of the difference.
Filler commonly runs $300–$600 per syringe at wholesale, and neuromodulator is bought by the 100-unit vial. Know both before you price any service — they drive your per-treatment margin.
Plan for three to six months of rent and payroll in reserve. It's the line item people underbudget most, and the one that keeps a slow first quarter from ending the business.
There's no profitability timeline anyone can honestly promise. Margins can be strong, but profit depends on your pricing, volume, and fixed costs. Startup cost and profit are separate questions.
The free 17-question assessment returns a state-specific 90-day launch plan: scope, entity, supplier sequence, and the exact next action for your scenario. 7 minutes. No card. Built by Faisal Darwiche, NP.
About the author
Faisal Darwiche, NP, is the founder of My Practice Academy. He's an AANP-certified nurse practitioner (MSN, adult-gerontology primary care) with 27+ years of clinical experience, a key opinion leader for leading aesthetic device companies, and faculty at The Aesthetic Show. He built an aesthetics practice up to ten treatment rooms and later sold it, and currently operates three practices — including Manal's Room, a lean single-room practice he opened in about 60 days. This article is general educational guidance, not legal, financial, or medical advice. Figures are illustrative ranges from his own experience, not income projections or guarantees.